Emerging drug therapies for frailty

Jeffery, Christopher A., Shum, David W. C. and Hubbard, Ruth E. (2013) Emerging drug therapies for frailty. Maturitas, 74 1: 21-25. doi:10.1016/j.maturitas.2012.10.010


Author Jeffery, Christopher A.
Shum, David W. C.
Hubbard, Ruth E.
Title Emerging drug therapies for frailty
Journal name Maturitas   Check publisher's open access policy
ISSN 0378-5122
1873-4111
Publication date 2013-01
Year available 2012
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1016/j.maturitas.2012.10.010
Open Access Status
Volume 74
Issue 1
Start page 21
End page 25
Total pages 5
Place of publication Shannon, Co. Clare, Ireland
Publisher Elsevier
Collection year 2013
Language eng
Abstract The metaphor of a frail older person as a car running out of petrol seems to have resonance in the lay media. Though it may be an over simplistic representation of a complex and dynamic process, it does facilitate discussion with patients and their relatives about the appropriateness of interventions, such as whether or not there is enough fuel (physiological reserves) to get up a really steep hill (undergo a coronary bypass graft). It can also be used as a way to emphasise what can be done to help. For example, in some longitudinal studies, 5% of older patients are less frail after 5 years follow up, suggesting there are things that can still be done to "fill up the tank". This review will consider whether drug therapies can fulfil this role. Frail older people are often prescribed long lists of medications but it is debatable whether current treatments actually address the causes or consequences of frailty itself. Here, we explore the associations between frailty and co-morbidity and evaluate whether the management of chronic disease may impact frailty development or progression. We consider how the management of hypertension may have an important role in the prevention of frailty, mediated by reduction of cerebrovascular disease, but why aggressive management of hypertension may have negative consequences for those who are already frail. We also summarise the evidence linking immunosenescence, inflammation and endocrine changes to frailty and investigate whether targeted drug therapy has the potential to influence frailty pathophysiology.
Keyword Frailty
Aged
80 and over
Drug therapy
Prevention
Q-Index Code CX
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Non HERDC
ERA White List Items
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 4 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 5 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 24 Feb 2013, 00:25:03 EST by System User on behalf of School of Medicine